Home โบ Lymphoma
Lymphoma clinical trials recruiting in the U.S.
140 studies for Lymphoma are recruiting participants at sites across the United States.
Lymphoma is a cancer affecting the immune system. Hodgkins Lymphoma and Non Hodgkins Lymphoma are types of lymphoma. Learn about symptoms and treatments.
Cities with the most studies
- Houston, TX34 studies
- Boston, MA34 studies
- New York City, NY33 studies
- Washington, DC23 studies
- Baldwin Park, CA22 studies
- Chicago, IL19 studies
- Durham, NC17 studies
- St. Louis, MO15 studies
- Cleveland, OH13 studies
- Seattle, WA13 studies
- Atlanta, GA13 studies
- Philadelphia, PA13 studies
- Edison, NJ12 studies
- Salt Lake City, UT11 studies
- Miami, FL11 studies
- Columbus, OH11 studies
- Queens, NY10 studies
- Pittsburgh, PA10 studies
- Rochester, MN10 studies
- Los Angeles, CA10 studies
- Dallas, TX10 studies
- Mountain View, CA10 studies
- Milwaukee, WI10 studies
- Nashville, TN10 studies
- Greenburgh, NY9 studies
- Portland, OR9 studies
- Cincinnati, OH9 studies
- Denver, CO9 studies
- Staten Island, NY8 studies
- East Norwalk, CT8 studies
- Aurora, CO8 studies
- Birmingham, AL8 studies
- New Rochelle, NY7 studies
- Omaha, NE7 studies
- Phoenix, AZ7 studies
- Tampa, FL7 studies
- San Antonio, TX7 studies
- New Haven, CT7 studies
- Buffalo, NY6 studies
- Winston-Salem, NC6 studies
By state
- Alabama9 studies
- Arizona11 studies
- Arkansas3 studies
- California40 studies
- Colorado16 studies
- Connecticut7 studies
- District of Columbia7 studies
- Florida24 studies
- Georgia16 studies
- Illinois22 studies
- Indiana5 studies
- Iowa6 studies
- Kansas6 studies
- Kentucky4 studies
- Maryland21 studies
- Massachusetts34 studies
- Michigan13 studies
- Minnesota13 studies
- Missouri17 studies
- Nebraska7 studies
- New Jersey18 studies
- New Mexico3 studies
- New York41 studies
- North Carolina22 studies
- Ohio28 studies
- Oklahoma4 studies
- Oregon9 studies
- Pennsylvania22 studies
- South Carolina4 studies
- Tennessee14 studies
- Texas44 studies
- Utah14 studies
- Virginia10 studies
- Washington13 studies
- Wisconsin13 studies
Recently updated studies
Study of Ruxolitinib in Relapsed or Refractory T or NK Cell Lymphoma
RecruitingPhase 2
Ages 18 and older ยท All sexes ยท Updated Nov 13, 2026 ยท NCT02974647A Study of Pembrolizumab (MK-3475) in Pediatric Participants With an Advanced Solid Tumor or Lymphoma (MK-3475-051/KEYNOTE-051)
RecruitingPhase 1/2
6 Months โ 17 Years ยท All sexes ยท Updated Nov 13, 2026 ยท NCT02332668Natural History Study of Monoclonal B Cell Lymphocytosis (MBL), Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (CLL/SLL), Lymphoplasmacytic Lymphoma (LPL)/Waldenstrom Macroglobulinemia (WM), and Splenic Marginal Zone Lymphoma (SMZL)
RecruitingObservational study
Ages 18 to 110 ยท All sexes ยท Updated Nov 12, 2026 ยท NCT00923507A Phase 2 Study of Epcoritamab in Patients With Follicular Lymphoma and Marginal Zone Lymphoma Not Accomplishing a Complete Response With Upfront Therapy
RecruitingPhase 2
Ages 18 and older ยท All sexes ยท Updated Nov 12, 2026 ยท NCT06510361Venetoclax, Ibrutinib, Prednisone, Obinutuzumab, and Revlimid (ViPOR) in Relapsed/Refractory B-cell Lymphoma
RecruitingPhase 1/2
Ages 18 to 120 ยท All sexes ยท Updated Nov 12, 2026 ยท NCT03223610A Phase 1 Study of JV-213 Autologous CD79b-targeting Chimeric Antigen Receptor T-cell Therapy in Adults With Relapsed or Refractory B-cell Lymphomas
RecruitingPhase 1
Ages 18 and older ยท All sexes ยท Updated Nov 12, 2026 ยท NCT05773040Pilot Trial of Fecal Microbiota Transplantation for Lymphoma Patients Receiving Axicabtagene Ciloleucel Therapy.
RecruitingPhase 2
Ages 18 and older ยท All sexes ยท Updated Nov 12, 2026 ยท NCT06218602Nivolumab in Epstein-Barr Virus (EBV)-Positive Lymphoproliferative Disorders and EBV-Positive Non-HodgkinLymphomas
RecruitingPhase 2
Ages 12 and older ยท All sexes ยท Updated Nov 12, 2026 ยท NCT03258567Testing the Addition of an Anti-cancer Drug, Lenalidomide, to the Usual Combination Chemotherapy Treatment ("EPOCH") for Adult T-Cell Leukemia-Lymphoma (ATLL)
RecruitingPhase 1
Ages 18 and older ยท All sexes ยท Updated Nov 12, 2026 ยท NCT04301076Natural History Study to Determine Drug Metabolism Phenotype and Appropriate Germline Source DNA in Patients Undergoing Allogeneic Hematopoietic Stem Cell Transplant
RecruitingObservational studyHealthy volunteers welcome
Ages 18 to 120 ยท All sexes ยท Updated Nov 9, 2026 ยท NCT06856226Living Well With Lymphoma
Recruiting
Ages 18 and older ยท All sexes ยท Updated Nov 9, 2026 ยท NCT06047626Cognitive Aftereffects of Neurotoxicity in Children and Young Adults With Relapsed/Refractory Hematologic Malignancies Who Receive CAR T-cell Therapy
RecruitingObservational studyHealthy volunteers welcome
Ages 5 and older ยท All sexes ยท Updated Nov 9, 2026 ยท NCT05237986HPC Offered for PRESERVE Expansion
RecruitingObservational study
Ages 12 to 80 ยท All sexes ยท Updated Nov 6, 2026 ยท NCT07145411A Study of the Efficacy and Safety of Lisocabtagene Maraleucel (Liso-cel) as First-Line Therapy in Adults With Transplant-Ineligible Primary Central Nervous System Lymphoma
RecruitingPhase 2
Ages 18 and older ยท All sexes ยท Updated Nov 5, 2026 ยท NCT07015242A Study to Evaluate Glofitamab as a Single Agent vs. Investigator's Choice in Participants With Relapsed/Refractory Mantle Cell Lymphoma
RecruitingPhase 3
Ages 18 and older ยท All sexes ยท Updated Nov 5, 2026 ยท NCT06084936cfDNA Assay Prospective Observational Validation for Early Cancer Detection and Minimal Residual Disease
RecruitingObservational studyHealthy volunteers welcome
Ages 40 and older ยท All sexes ยท Updated Nov 4, 2026 ยท NCT05366881A Study to Investigate Ronde-cel Versus Investigator's Choice CD19 CAR T-Cell Therapy
RecruitingPhase 3
Ages 18 and older ยท All sexes ยท Updated Nov 4, 2026 ยท NCT07188558A Study of NX-5948 in Adults With CLL/SLL Previously Treated With a Bruton's Tyrosine Kinase Inhibitor and a B-cell Lymphoma-2 Inhibitor (DAYBreak CLL-201)
RecruitingPhase 2
Ages 18 and older ยท All sexes ยท Updated Nov 3, 2026 ยท NCT07221500A Randomized Phase II Study Of Bruton Tyrosine Kinase Inhibitor With Or Without Venetoclax In Veterans With Chronic Lymphocytic Leukemia (CLL)/Small Lymphocytic Lymphoma (SLL)
RecruitingPhase 2
Ages 18 to 80 ยท All sexes ยท Updated Oct 30, 2026 ยท NCT06520098Mosaic Trial for Stem Cell Transplant Recipients
Recruiting
Ages 18 and older ยท All sexes ยท Updated Oct 30, 2026 ยท NCT06960993Study to Evaluate CD8 PET Imaging as a Marker of Immune Response to Stereotactic Body Radiation Therapy (ELIXR)
RecruitingPhase 1
Ages 18 and older ยท All sexes ยท Updated Oct 30, 2026 ยท NCT05371132Non-covalent BTK Inhibitor Nemtabrutinib in Combination With the CD20 Monoclonal Antibody Rituximab for the Treatment of Marginal Zone Lymphoma
RecruitingPhase 2
Ages 18 and older ยท All sexes ยท Updated Oct 29, 2026 ยท NCT07583810Pharmacokinetic Study of Venetoclax Tablets Crushed and Dissolved Into a Solution
RecruitingObservational study
Ages 0 to 38 ยท All sexes ยท Updated Oct 29, 2026 ยท NCT06131801A Study to Evaluate the Safety and Pharmacokinetics of Eflapegrastim in Pediatric Participants With Solid Tumors or Lymphomas and Treated With Myelosuppressive Chemotherapy
RecruitingPhase 2
1 Month โ 17 Years ยท All sexes ยท Updated Oct 28, 2026 ยท NCT04570423HEME Home Transfusion Program
Recruiting
Ages 18 and older ยท All sexes ยท Updated Oct 28, 2026 ยท NCT06487247From ClinicalTrials.gov, data retrieved Nov 15, 2026. Each study sets its own eligibility; the study team decides who can join.